Some people with acute myeloid leukaemia (AML) have difficulty tolerating intensive chemotherapy. For them, venetoclax provides a promising alternative treatment. Up to two thirds of patients achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results